Autologous Fat Graft
Autologous Fat Graft - Related Videos
04:16
Stromal Vascular Fraction-Enriched Fat Grafting for the Management of Symptomatic Neuromas
0 Views •
2025
Source: Zimmermann, S., et.al. Stromal Vascular Fraction-enriched Fat Grafting for the Treatment of Symptomatic End-neuromata. J. Vis. Exp. (2017)This video demonstrates the surgical procedure for neurolysis and stromal vascular fraction (SVF)-enriched fat grafting in the management of symptomatic neuroma. Neurolysis removes adhesion tissue to restore nerve gliding, while SVF-enriched fat grafting is applied around the nerve to create a protective barrier, support nerve healing, and enhance...
07:58
Stromal Vascular Fraction-enriched Fat Grafting for the Treatment of Symptomatic End-neuromata
0 Views •
Cited by 8 •
2017
The purpose of the study is to illustrate the technical procedure of stromal vascular fraction (SVF)-enriched fat grafting as a novel treatment of symptomatic end-neuromata. This technique provides advantages of both the mechanical barrier and the biological action at the cellular level by the processed and concentrated SVF.
09:25
Transplantation Into the Mouse Ovarian Fat Pad
0 Views •
Cited by 7 •
2016
We describe an ovarian fad pad transplantation assay suitable for studies of normal and transformed epithelia of the female reproductive tract. The mouse fat pad allows transplantation of large tissue fragments, is easily accessible for surgery and imaging, and provides the most favorable native environment for tissues of Müllerian origin.
09:30
Tissue Characterization after a New Disaggregation Method for Skin Micro-Grafts Generation
0 Views •
Cited by 44 •
2016
The protocol describes a new method to disaggregate human tissues and to create autologous micro-grafts that, combined with collagen sponges, give rise to human bio-complexes ready to use in the treatment of skin lesions. Further, this system preserves cell viability of micro-grafts at different times after mechanical disaggregation.
10:30
Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications
0 Views •
Cited by 28 •
2016
Culturing human Mesenchymal Stromal Cells (hMSCs) with autologous serum, reduces the risks of rejection by xenogeneic material and other negative effects. It also allows for the recovery of a subset of mesodermal progenitors, which can deliver fresh hMSCs. Embedding hMSCs in an autologous fibrin clot enables easy handling and effective surgical implantation.
FAQs
Transferred adipocytes must establish a blood supply in the recipient tissue to survive. This vascular connection is a central biological requirement because the final result depends not simply on how much tissue is placed, but on how much transferred fat remains viable. Tissue conditions and injection technique therefore influence whether the graft contributes lasting volume or contour.
Outcome depends on several linked factors: how the graft is handled, the condition of the recipient tissue, and how fat is injected into the target area. These variables influence the proportion of transferred fat that remains viable. Consequently, procedures intended to restore similar defects may produce different degrees of retained volume or contour correction.
Using tissue obtained from the same patient can reduce reliance on synthetic fillers. This approach may be relevant when restoring volume, contouring tissue, addressing age-related volume loss, or supporting selected reconstruction. Its results still depend on the survival of transferred adipocytes, so the biological behavior of the graft remains important when considering this option.
Preparation focuses on removing unwanted fluids and debris from the harvested tissue before it reaches the recipient site. The processed graft is then carefully injected into the area requiring volume or contour support. This sequence links tissue preparation to delivery, making processing and placement distinct procedural stages within the overall treatment.
Within medicine, clinicians may consider this approach for soft-tissue defects, age-related volume loss, scarring, and selected reconstructive needs. The target problem determines whether the goal is to restore volume, improve contour, or support reconstruction. Its use therefore extends beyond cosmetic contouring to situations where tissue restoration has a reconstructive role.
The clinically relevant outcome is not the initial amount transferred alone, but the proportion that remains viable. Retained fat determines how much restored volume or contour persists after the procedure. Evaluating results therefore requires attention to graft survival as well as the intended target, because transfer quantity by itself does not describe the final outcome.